Recombinant streptokinase: evidences from clinical use: reply
نویسندگان
چکیده
منابع مشابه
Heberkinasa: recombinant streptokinase.
I would like to comment about Heberkinasa (recombinant streptokinase): one of the preparations included in the article written by Dr Hermentin et al. 1 The quality control system of the Center of Genetic Engineering and Biotechnology has been successfully evaluated by the World Health Organization and another International Regulatory Organizations. The biological activity of the Heberkinasa bat...
متن کاملDrotrecogin alfa (activated) in clinical practice and current evidences: reply.
1. PhD, Physician from the Intensive Care Center of Instituto Nacional de CâncerINCA, Rio de Janeiro (RJ), Brazil. 2. PhD, Associate Professor from the Universidade Federal de Santa Catarina UFSC, Florianópolis (SC), Brazil 3. Intensive Care Fellow from the Instituto Nacional de CâncerINCA, Rio de Janeiro (RJ), Brazil. 4. Master, Physician from the Intensive Care Center and Critical Care Clinic...
متن کاملExpression of Recombinant Streptokinase from Streptococcus Pyogenes and Its Reaction with Infected Human and Murine Sera
Objective(s): Streptokinase (SKa) is an antigenic protein which is secreted by Streptococcus pyogenes. Streptokinase induces inflammation by complement activation, which may play a role in post infectious diseases. In the present study, recombinant streptokinase from S. pyogenes was produced and showed that recombinant SKa protein was recognized by infected human sera using Western blot analy...
متن کاملA new recombinant factor VIII: from genetics to clinical use
Advances in recombinant technology and knowledge about coagulation factor VIII (FVIII) are building a platform for new therapeutic options in patients with hemophilia A. The development of turoctocog alfa, a novel, high-purity, third-generation, B-domain truncated recombinant FVIII, has been produced and formulated without the use of animal-derived or human serum-derived components, in the wake...
متن کاملMesoglycan: Clinical Evidences for Use in Vascular Diseases
Vascular glycosaminoglycans (GAG) are essential components of the endothelium and vessel wall and have been shown to be involved in several biologic functions. Mesoglycan, a natural GAG preparation, is a polysaccharide complex rich in sulphur radicals with strong negative electric charge. It is extracted from porcine intestinal mucosa and is composed of heparan sulfate, dermatan sulfate, electr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Heart Journal
سال: 2005
ISSN: 1522-9645,0195-668X
DOI: 10.1093/eurheartj/ehi320